Young adults' knowledge, perceptions and use of cannabidiol products: a mixed-methods study.
Study Design
- अध्ययन प्रकार
- Observational Study
- नमूना आकार
- 2464
- जनसंख्या
- US young adults, mean age 24.67y
- हस्तक्षेप
- Young adults' knowledge, perceptions and use of cannabidiol products: a mixed-methods study. None
- तुलनित्र
- None
- प्राथमिक परिणाम
- CBD knowledge, perceptions, and use
- प्रभाव की दिशा
- Neutral
- पूर्वाग्रह का जोखिम
- Unclear
Abstract
Cannabidiol (CBD) product regulatory efforts must be informed by research regarding consumer perceptions. This mixed-methods study examined CBD product information sources, knowledge, perceptions, use and use intentions among young adults. This study analyzed (i) Fall 2020 survey data from 2464 US young adults (Mage = 24.67, 51.4% ever users, 32.0% past 6-month users) and (ii) Spring 2021 qualitative interviews among 40 survey participants (27.5% past-month users). Overall, 97.9% of survey participants reported having heard of CBD, 51.4% ever/lifetime use and 32.0% past 6-month use. Survey participants learned about CBD from friends/family (58.9%), products/ads at retailers (36.4%), online content/ads (34.8%), CBD stores (27.5%) and social media (26.7%). One-fourth believed that CBD products were required to be US Food and Drug Administration-approved (24.9%), tested for safety (28.8%) and proven effective to be marketed for pain, anxiety, sleep, etc. (27.2%). Survey and interview participants perceived CBD as safe, socially acceptable and effective for addressing pain, anxiety and sleep. Interview findings expanded on prominent sources of marketing and product exposure, including online and specialty retailers (e.g. vape shops), and on participants' concerns regarding limited regulation and/or evidence regarding CBD's effectiveness/risks. Given young adults' misperceptions about CBD, surveillance of CBD knowledge, perceptions and use is critical as the CBD market expands.
संक्षेप में
Survey and interview participants perceived CBD as safe, socially acceptable and effective for addressing pain, anxiety and sleep, and on participants' concerns regarding limited regulation and/or evidence regarding CBD's effectiveness/risks.
Used In Evidence Reviews
Similar Papers
Sleep · 2005
Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial.
Journal of psychopharmacology (Oxford, England) · 2005
Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability.
Phytotherapy research : PTR · 2018
GABA-modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence.
Molecules (Basel, Switzerland) · 2022
Medicinal Plants Used for Anxiety, Depression, or Stress Treatment: An Update.
Medical science monitor : international medical journal of experimental and clinical research · 2009
Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian.
Integrative cancer therapies · 2004